(¿Â¶óÀÎ) KSC 2020 (´ëÇѽÉÀåÇÐȸ Á¦64Â÷ Ãß°èÇмú´ëȸ) 1ÀÏÂ÷ : 2020-10-16±³À°ÀÏÀÚ : 2020-10-16
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À° (½Ç½Ã°£ È»ó °ÀÇ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) KSC 2020 (´ëÇѽÉÀåÇÐȸ Á¦64Â÷ Ãß°èÇмú´ëȸ) 1ÀÏÂ÷ ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258
À̸ÞÀÏ :
herz8@circulation.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í ±³¼ö ¹× °³¿øÀÇ-20000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-10000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 08:40~08:52 Pro: Swan-Ganz Catheter in Cardiac Critical Care: It Should Be Done in Some Cases ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 08:52~09:04 Con: Echocardiographic Hemodynamic Monitoring Is Enough ±è¹Ì³ª(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 09:04~09:09 Pro Rebuttal ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 09:09~09:14 Con Rebuttal ±è¹Ì³ª(°í·ÁÀÇ´ë)
Åä·Ð 10¿ù 16ÀÏ ¿Â¶óÀÎ 09:14~09:25 Discussion ()
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 09:25~09:37 Pro: Awake ECMO, Pros À̼ö¿ë(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 09:37~09:49 Con: Awake ECMO, Cons À̼±±â(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 09:49~09:54 Pro Rebuttal À̼ö¿ë(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 09:54~09:59 Con Rebuttal À̼±±â(ÇѸ²ÀÇ´ë)
Åä·Ð 10¿ù 16ÀÏ ¿Â¶óÀÎ 09:59~10:10 Discussion ()
ÈÞ½Ä 10¿ù 16ÀÏ 10:10~10:20 Break ()
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 10:20~10:30 The Trend and Burden of Korean AF ¾çÇʼº(Â÷ÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 10:30~10:40 Risk Stratification of Thromboembolism À̱¤³ë(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 10:40~10:50 Imaging Modalities for AF Treatment ÀÌÁ¤¸í(°æÈñÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 10:50~11:00 Korean Practical Guideline of NOAC Use ¹ÚÁø±Ô(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 11:00~11:10 Selection of NOAC À̼ҷÉ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 11:10~11:20 Wearable Monitoring and Opportunistic Screening of AF: State of the Art ¹é¿ë¼ö(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 11:20~11:30 How to Apply Korean Anticoagulation Guideline in PCI Patients ȲÀ¯¹Ì(°¡Å縮ÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 11:30~11:40 Non-genetic Risk Factor for AF ±èÀ±±â(°í·ÁÀÇ´ë)
Åä·Ð 10¿ù 16ÀÏ 11:40~11:50 Discussion ()
ÈÞ½Ä 10¿ù 16ÀÏ 11:50~12:00 Break ()
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 12:00~12:20 The evolution of the ESC atrial fibrillation management guideline ½Å½Â¿ë(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 12:20~12:40 Antithrombotic therapy in patients with NVAF undergoing PCI : Would you choose Eliquis? ³²Ã¢¿í(°è¸íÀÇ´ë)
ÈÞ½Ä 10¿ù 16ÀÏ 12:40~14:00 Break ()
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 14:00~14:10 Introduction- Incidence Epidemiology Risk ¾çÇʼº(Â÷ÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 14:10~14:20 AF Causing HF Versus HF Causing AF: Can We Tell One the Other ±èÀÀÁÖ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 14:20~14:30 Optimal Management of the Patients with AF and HF: Anticoagulation and Antiarrhythmic Drugs ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 14:30~14:40 Optimal Management of the Patients with AF and HF: Beta-blocker Still Useful? ¹ÚÁøÁÖ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 14:40~14:50 Role of AF Ablation in HF - AF Ablation vs. AV Node Ablation and CRT as Primary Therapy ¹ÚÇü¼·(°è¸íÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 14:50~15:00 AF in HF: Ablate or Not? ÀÌ»ó¾ð(¿ï»êÀÇ´ë)
Åä·Ð 10¿ù 16ÀÏ ¿Â¶óÀÎ 15:00~15:30 Discussion ()
ÈÞ½Ä 10¿ù 16ÀÏ 15:30~15:40 Break ()
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 15:40~16:00 Embryology of Conduction System ±èÁ¤¼±(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 16:00~16:20 His-purkinje System ¿ÀÀÏ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 16:20~16:40 Cardiac Conduction System in Congenital Heart Disease S Yen Ho(Royal Brompton Hospital UK)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 16:40~17:00 Cardiac Conduction System for Electrophysiologist S Yen Ho(Royal Brompton Hospital UK)
Åä·Ð 10¿ù 16ÀÏ 17:00~17:10 Discussion ()
ÈÞ½Ä 10¿ù 16ÀÏ 17:10~17:20 Break ()
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 17:20~17:35 Remote Monitoring by Implantable Devices Á¤º¸¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 17:35~17:50 Remote Monitoring by Wearable Devices ¿ÀÀÏ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 17:50~18:05 Ubiquitous Blood Pressure Monitoring by New Technologies ¹ÚÁغó(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 16ÀÏ ¿Â¶óÀÎ 18:05~18:20 Pro and Cons of Telemonitoring of ICU Àü±âÇö(¸ÞµðÇ÷º½º¼¼Á¾º´¿ø)
Åä·Ð 10¿ù 16ÀÏ 18:20~18:50 Discussion ()